Fecal microbiota therapy in recurrent and refractory clostridium difficile infections has been associated with positive results in immunocompromised patients

Abstract

<p>A critical appraisal and clinical application of Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. <em>The American Journal of Gastroenterology</em>, 2014;<em>109</em>(7):1065-71. doi: <a href="https://doi.org/10.1038/ajg.2014.133">10.1038/ajg.2014.133</a></p>